Sg Americas Securities, LLC Intercept Pharmaceuticals, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$12.21 - $19.7 $1.09 Million - $1.76 Million	89,125 Added 78.79%	202,239 $2.82 Million
Q2 2022 Jul 29, 2022	BUY	$11.23 - $19.59 $1.27 Million - $2.22 Million	113,114 New	113,114 $1.56 Million
Q4 2021 Feb 07, 2022	SELL	$14.28 - $19.53 $542,468 - $741,905	-37,988 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$12.99 - $20.47 $226,324 - $356,648	17,423 Added 84.72%	37,988 $564,000
Q2 2021 Aug 12, 2021	SELL	$15.46 - $24.5 $63,973 - $101,381	-4,138 Reduced 16.75%	20,565 $411,000
Q1 2021 May 13, 2021	SELL	$19.33 - $37.75 $133,802 - $261,305	-6,922 Reduced 21.89%	24,703 $570,000
Q4 2020 Feb 04, 2021	BUY	$24.48 - $42.47 $182,841 - $317,208	7,469 Added 30.92%	31,625 $781,000
Q3 2020 Nov 09, 2020	BUY	$39.09 - $53.44 $634,665 - $867,651	16,236 Added 205.0%	24,156 $1 Million
Q2 2020 Jul 20, 2020	SELL	$46.7 - $92.04 $1.28 Million - $2.52 Million	-27,427 Reduced 77.59%	7,920 $379,000
Q1 2020 Apr 30, 2020	BUY	$48.35 - $118.68 $1.5 Million - $3.67 Million	30,957 Added 705.17%	35,347 $2.23 Million
Q4 2019 Jan 28, 2020	SELL	$57.36 - $124.1 $123,610 - $267,435	-2,155 Reduced 32.93%	4,390 $544,000
Q3 2019 Nov 04, 2019	BUY	$58.69 - $80.46 $195,907 - $268,575	3,338 Added 104.08%	6,545 $434,000
Q2 2019 Jul 29, 2019	SELL	$77.77 - $120.68 $131,897 - $204,673	-1,696 Reduced 34.59%	3,207 $255,000
Q1 2019 Apr 29, 2019	SELL	$91.83 - $120.68 $1.42 Million - $1.86 Million	-15,426 Reduced 75.88%	4,903 $548,000
Q4 2018 Feb 01, 2019	BUY	$85.79 - $126.46 $145,843 - $214,982	1,700 Added 9.13%	20,329 $2.05 Million
Q3 2018 Nov 06, 2018	BUY	$88.49 - $127.55 $1.38 Million - $1.99 Million	15,611 Added 517.26%	18,629 $2.35 Million
Q2 2018 Aug 07, 2018	SELL	$60.0 - $85.67 $1.92 Million - $2.75 Million	-32,069 Reduced 91.4%	3,018 $253,000
Q1 2018 May 03, 2018	BUY	$52.72 - $67.25 $345,632 - $440,891	6,556 Added 22.98%	35,087 $2.16 Million
Q4 2017 Jan 24, 2018	BUY	$58.2 - $72.76 $925,612 - $1.16 Million	15,904 Added 125.95%	28,531 $1.67 Million
Q3 2017 Nov 07, 2017	BUY	$57.01 - $118.75 $719,865 - $1.5 Million	12,627	12,627 $733,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account